/
RADX
$4.13+$0.11 (+2.74%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$31.7M
8M shares
52-week range
$3.62 – $16.25
4% from low
Exchange
NASDAQ
ADRC
Price (6 mo)
Loading chart…
Change$-13.54
Radiopharm Theranostics Limited American Depositary Shares
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
www.radiopharmtheranostics.com- Employees
- 14
- IPO / List date
- Nov 27, 2024
Held by traders on TradeandTell
No one on the platform currently holds RADX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in RADX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded RADX yet.
